Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Vir Biotechnology
Sort By
Newest First
1 / 1
COVID-19
Vir and Alnylam Identify RNAi Therapeutic Development Candidate Targeting SARS-CoV-2
Vir Biotechnology
PR-M05-20-NI-008
May 04, 2020
Coronavirus
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19
WuXi Biologics
PR-M02-20-NI-033
Feb 25, 2020
1 / 1
